Top 10 Most Profitable NASDAQ Stocks: AGNC, CPLP, PSEC, MNTA, DEPO, DMLP, AKRX, CYOU, KEYN, NBIX (Jan 16, 2012)

Below are the top 10 most profitable stocks in the NASDAQ Composite index for
the last 12 months. One Chinese company (CYOU) is on the list. American Capital
Agency Corp. (NASDAQ:AGNC) is the 1st most profitable stock in this segment of
the market. Its net profit margin was 81.66% for the last 12 months. Its
operating profit margin was 81.82% for the same period. Capital Product Partners
L.P. (NASDAQ:CPLP) is the 2nd most profitable stock in this segment of the
market. Its net profit margin was 76.69% for the last 12 months. Its operating
profit margin was 32.18% for the same period. Prospect Capital Corporation
(NASDAQ:PSEC) is the 3rd most profitable stock in this segment of the market.
Its net profit margin was 69.91% for the last 12 months. Its operating profit
margin was 53.32% for the same period. Momenta Pharmaceuticals, Inc.
(NASDAQ:MNTA) is the 4th most profitable stock in this segment of the market.
Its net profit margin was 69.84% for the last 12 months. Its operating profit
margin was 69.40% for the same period. DepoMed, Inc. (NASDAQ:DEPO) is the 5th
most profitable stock in this segment of the market. Its net profit margin was
60.88% for the last 12 months. Its operating profit margin was 59.79% for the
same period. Dorchester Minerals L.P. (NASDAQ:DMLP) is the 6th most profitable
stock in this segment of the market. Its net profit margin was 58.71% for the
last 12 months. Its operating profit margin was 58.58% for the same period.
Akorn, Inc. (NASDAQ:AKRX) is the 7th most profitable stock in this segment of
the market. Its net profit margin was 51.57% for the last 12 months. Its
operating profit margin was 18.59% for the same period. Changyou.com
Limited(ADR) (NASDAQ:CYOU) is the 8th most profitable stock in this segment of
the market. Its net profit margin was 50.66% for the last 12 months. Its
operating profit margin was 57.94% for the same period. Keynote Systems, Inc.
(NASDAQ:KEYN) is the 9th most profitable stock in this segment of the market.
Its net profit margin was 49.37% for the last 12 months. Its operating profit
margin was 14.60% for the same period. Neurocrine Biosciences, Inc.
(NASDAQ:NBIX) is the 10th most profitable stock in this segment of the market.
Its net profit margin was 48.43% for the last 12 months. Its operating profit
margin was 41.70% for the same period.